Hospira has emerged as a bidder for Danone's medical-nutrition unit in a deal that could be worth about $5 billion and mark the latest in a flurry of so-called inversion deals.
via WSJ.com: US Business http://ift.tt/1oyaILj
via WSJ.com: US Business http://ift.tt/1oyaILj
Nessun commento:
Posta un commento